Boston Scientific


 

Who Should Receive Cerebral Embolic Protection

December 18, 2020

This is video #7 of a 7 part series on Cerebral Embolic Protection for Ischemic Stroke.

In this recorded interactive Q&A session from the SENTINEL Therapy Awareness webinar, Drs. Hemal Gada and David Rose answer questions on device deployment, patient selection, and the PROTECTED TAVR clinical trial. 

0 Comments
Login to view comments. Click here to Login